πŸ‡ΊπŸ‡Έ FDA
Patent

US 6063794

Selective factor Xa inhibitors

expired A61KA61K38/00

Quick answer

US patent 6063794 (Selective factor Xa inhibitors) held by COR Therapeutics, Inc. expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
COR Therapeutics, Inc.
Grant date
Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/00